447
Views
7
CrossRef citations to date
0
Altmetric
Articles

The Economic Driven by Politics as Values: The Example of Pharmaceuticals in France

Pages 611-627 | Received 04 Jul 2016, Accepted 21 Jan 2017, Published online: 07 Feb 2017

References

  • Abdelal, R., Blyth, M., and Parsons, C. (eds) (2010), Constructing the International Economy (Ithaca, NY: Cornell University Press).
  • Amable, B. and Palombrini, S. (2008), ‘A Neorealist Approach to Institutional Change and the Diversity of capitalism’, Socio-Economic Review, 7 (1), pp. 123–43. doi: 10.1093/ser/mwn018
  • Ansaloni, M., Pariente A. and Smith A. (2017) ‘Power Shifts in the Regulation of Medicines: An Inter-Field Analysis of the French Case’. Under review by a journal.
  • Baker, A. (2015), ‘Varieties of Economic Crisis, Varieties of Ideational Change: How and Why Financial Regulation and Macroeconomic Policy Differ’, New Political Economy, 20 (3), pp. 342–66. doi: 10.1080/13563467.2014.951431
  • Barker, R. (2011), 2030 The Future of Medicine. Avoiding a Medical Meltdown (Oxford: Oxford University Press).
  • Bégaud, B. (1995) Dictionnaire de Pharmaco-épidémiologie (Bordeaux: ARME-Pharmacovigilance).
  • Bégaud, B. and Dangoumau, J. (2000), ‘Pharmaco-épidémiologie: Définition, Problèmes, Méthodologie’, Thérapie, 55 (1), pp. 113–17.
  • Beramendi, P., Häusermann, S., Kitschelt, H. and Kriesi, H. (eds) (2015), The Politics of Advanced Capitalism (Cambridge: Cambridge University Press).
  • Bergeron, H. and Nathanson, C. (2012), ‘Construction of a Policy Arena: the Case of Public Health in France’, Journal of Health Politics, Policy and Law, 37 (1), pp. 5–36. doi: 10.1215/03616878-1496002
  • Boudon, R. (1999), ‘La rationalité axiologique: une notion essentielle pour l’analyse des phénomènes normatives’, Sociologies et societies, 31 (1), pp. 103–17. doi: 10.7202/001082ar
  • Campana, A., Henry, E. and Rowell, J. (eds) (2007), La Construction de problèmes publics en Europe (Strasbourg: Presses Universitaires de Strasbourg).
  • Carpenter, D. (2010), Reputation and Power. Organizational Image and Pharmaceutical Regulation at the FDA (Princeton, NJ: Princeton University Press).
  • Carpenter, D., and Moss, D. (eds) (2013), Preventing Regulatory Capture. Special Interest Influence and How to Limit It (Cambridge, MA: Cambridge University Press).
  • Carter, C. (2013) ‘Constructing Sustainability in EU Fisheries: Redrawing the Boundary Between Science and Policies?’, Environmental Science and Policy, (30), pp. 26–35. doi: 10.1016/j.envsci.2012.11.015
  • Charles, N. (2015), Ce que éduquer veut dire (Paris: La Documentation Française).
  • Craig, M. (2015), ‘Post-2008 British Industrial Policy and Constructivist Political Economy: New Directions and New Tensions’, New Political Economy, 20 (1), pp. 107–25. doi: 10.1080/13563467.2014.908176
  • Dabrowska, E. and Zweynert, J. (2015), ‘Economic Ideas and Institutional Change: The Case of the Russian Stabilisation Fund’, New Political Economy, 20 (4), pp. 518–44. doi: 10.1080/13563467.2014.923828
  • Douglas, M., (1982) ‘Cultural Bias’, in M. Douglas (eds), In the Active Voice (London: Routledge and Kegan Paul), pp. 183–254.
  • Eckersley, R. (2016), ‘National Identities, International Roles and the Legitimation of Climate Leadership: Germany and Norway Compared’, Environmental Politics, 25 (1), pp. 180–201. doi: 10.1080/09644016.2015.1076278
  • Ellis, R.J. and Thompson, M. (eds) (1997), Culture Matters, Essays in Honor of Aaron Wildasky (Boulder, CO: Westview Press).
  • Fligstein, N., McAdam, D. (2012), A Theory of Fields (Oxford: Oxford University Press).
  • Gilpin, R. (1987), The Political Economy of International Relations (Princeton, NJ: Princeton University Press).
  • Gusfield, J. (1981), The Culture of Public Problems. Drink-Driving and the Symbolic Order (Chicago, IL: University of Chicago Press).
  • Hall, S. (ed.) (1997), Representation: Cultural Representations and Signifying Practices (London: Sage).
  • Hall, P. and Thelen, K. (2008), ‘Institutional Change in Varieties of Capitalism’, Socio-Economic Review, 7 (1), pp. 7–34. doi: 10.1093/ser/mwn020
  • Hall, P. and Soskice, D. (eds) (2001), Varieties of Capitalism (Oxford: Oxford University Press).
  • Hauray, B. (2006), L’Europe du médicament. Politique, expertise, intérêts publics (Paris: Presses de Sciences Po).
  • Hay, C. (2002) Political Analysis. A Critical Introduction (Basingstoke: Palgrave).
  • Hay, C. (2007), Why We Hate Politics (Cambridge: Polity).
  • Hay, C. (2016), ‘Good in a Crisis: The Ontological Institutionalism of Social constructivism’, New Political Economy, 21 (6), pp. 520–35. doi: 10.1080/13563467.2016.1158800
  • Huising, R. and Silbey S. (2011) ‘Governing the GAP: Forging Sage Science Through Relational Regulation’, Regulation and Governance, 5, pp. 14–42. doi: 10.1111/j.1748-5991.2010.01100.x
  • Jasanoff, S. (2006) States of Knowledge: The Co-Production of Science and the Social Order (London: Routledge).
  • Jorgensen, D. and Mam Renofalt, B. (2015), ‘Damned If You Do, Damned If You Don’t: Debates on Dam Removal in the Swedish Media’, Ecology and Society, 18 (1), pp. 18. doi:10.5751/ES-05364-180118
  • Kalberg, S. (2010), Les valeurs, les idées et les intérêts. Introduction à la sociologie de Max Weber (Paris: La Découverte).
  • Lagroye, J. (1985), ‘La légitimation’, in M. Grawitz and J. Leca (eds), Traité de Science Politique, vol. 1, (Paris: Presses Universitaires de France), pp. 395–467.
  • Lascoumes, P. and Le Galès, P. (eds), (2007), ‘Introduction: Understanding Public Policy Through its Instruments’, Governance, 20 (1), pp. 1–21. doi: 10.1111/j.1468-0491.2007.00342.x
  • Mangenot, M. and Rowell, J. (2010), ‘Introduction: What Europe Constructs: Towards a Sociological constructivism’, in J. Rowell and M. Mangenot (eds), A Political Sociology of the European Union. Reassessing Constructivism (Manchester: Manchester University Press), pp. 1–22.
  • Marchetti, D. (2010), Quand la santé devient médiatique. Les logiques de production de l'information dans la presse (Grenoble: Presses Universitaires de Grenoble).
  • Morelle, A. and Padic, M.-O. (2011), ‘Mediator: l’histoire d’une seconde défaite de la santé publique’, Esprit, (5), pp. 71–9. doi: 10.3917/espri.1105.0071
  • Nouguez, E. (2015), “Marché du médicament”, in E. Henry, C. Gilbert, J.-N. Jouzel and P. et Marichalar (eds), Dictionnaire critique de l’expertise: santé, travail, environnement (Paris: Presses de Sciences Po), pp. 209–16.
  • Oatley, T. (2011) ‘The Reductionist Gamble: Open Economy Politics in the Global Economy’, International Organization, 65 (2), pp. 311–41. doi: 10.1017/S002081831100004X
  • Permanaud, G. (2006), EU Pharmaceuticals Regulation (Manchester: Manchester University Press).
  • Pinson, G., Sala Pala, V. (2007), ‘Peut-on vraiment se passer de l’entretien en sociologie de l’action publique?’, Revue Française de Science Politique, 57 (5), pp. 555–97. doi: 10.3917/rfsp.575.0555
  • Radaelli, C. (1999), Technocracy in the European Union (London: Longman).
  • Rochefort, D. and Cobb, R. (1994), The Politics of Problem Definition (Lawrence: University Press of Kansas).
  • Roger, A. (2010), ‘Scholarly Constructs and the Legitimization of European Policies. The Circulation of Knowledge on Wine and the vine’, Revue Française de Science Politique, 60 (2), pp. 1–22. doi: 10.3917/rfspe.602.0001
  • Sabatier, P. (1998) ‘The Advocacy Coalition Framework: Revision and Relevance for Europe’, Journal of European Public Policy, 5 (1), pp. 98–130. doi: 10.1080/13501768880000051
  • Schäfer, A. and Streeck, W. (eds) (2013), Politics in the Age of Austerity (Cambridge: Polity Press).
  • Schwartz, S. (2006), ‘Les valeurs de base de la personne: théorie, mésures et applications’, Revue Française de Sociologie, 47 (4), pp. 929–68. doi: 10.3917/rfs.474.0929
  • Schwartz, S. (2012), ‘An Overview of the Schwartz Theory of Basic Values’, Online Readings in Psychology and Culture, 2(1). doi:10.9707/2307-0919.1116
  • Smith, A. (2014), ‘How the European Commission’s Policies are Made: Problematization, Instrumentation and Legitimation’, Journal of European Integration, 36 (1), pp. 55–72. doi: 10.1080/07036337.2013.809344
  • Smith, A. (2016), The Politics of Economic Activity (Oxford: Oxford University Press).
  • Sommet, A., Bagheri, H. and Montastruc, J.-L. (2007), ‘De la pharmacovigilance à la gestion des risques’, La lettre du pharmacologue, 21, pp. 26–7.
  • Thatcher M. (2010), Governance Structures and Health Technology Assessment Agencies: a Comparative Approach (London: Department of Government, London School of Economics and Political Science ( unpublished).
  • Thompson, M., Ellis, R. and Wildavsky, A. (1990), Cultural Theory (Boulder, CO: Westview Press).
  • Tirole, J. (2016), Economie du bien commun (Paris: Presses Universitaires de France).
  • Troude-Chastenet, P. (2011), ‘Santé publique et démocratie: l’affaire du Médiator’, Etudes, 415, pp. 185–96.
  • Urfalino, Ph. (2001), ‘L’autorisation de mise sur le marché du médicament: une décision administrative à la fois sanitaire et économique’, Revue française des affaires sociales, 4 (4), pp. 85–90.
  • Van Apeldoorn, B., Drahokoupil, J. and Horn, L. (eds) (2009), Contradictions and Limits of Neoliberal European Goverance (Basingstoke: Palgrave).
  • Verba, S. (1987), Elites and the Idea of Equality (Cambridge, MA: Harvard University Press).
  • Wildavsky, A. (1987), ‘Choosing Preferences by Constructing Institutions: A Cultural Theory of Preference Formation’, American Political Science Review 81 (1), pp. 3–21. doi: 10.2307/1960776

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.